Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram effects on cognition and emotion in healthy volunteers
NCT04239339Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), anxiety disorder, sponsored by Rigshospitalet. Started Apr 2020; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT04239339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04239339.